Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 9INDUSTRY 5NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 13Thoracic 7Lymphoid 6CNS 6Other hematologic neoplasm 5Gynecologic 5Sarcoma 4Plasma cell 4Head & Neck 4Gastrointestinal 4Dermatologic 4Other solid neoplasm 3Myeloid 3Endocrine 3NET 2Breast 2

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Mesothelioma, Malignant 1Central Nervous System Metastases 1

Interventions

Cisplatin 28Irinotecan 18Gemcitabine 18Paclitaxel 14alvocidib 13Fluorouracil 11Oxaliplatin 10Cyclophosphamide 10Carboplatin 10Leucovorin 8Bortezomib 8Biopsy 8Taxes 7Radiotherapy 7Pemetrexed 7Magnetic Resonance Spectroscopy 7Doxorubicin 73-aminopyridine-2-carboxaldehyde thiosemicarbazone 7Specimen Handling 6tanespimycin 5Vorinostat 5LMB-100 5Early Intervention, Educational 5Bevacizumab 5temsirolimus 4sargramostim 4Sorafenib 4Sirolimus 4Platinum 4Decitabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Sunitinib × Other solid neoplasm × Clear all
NCT00392444 2014-05-21

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

National Cancer Institute (NCI)

Phase 2 Completed
39 enrolled 5 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00357318 2014-02-24

Bevacizumab and Sunitinib in Treating Patients With Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
60 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00387920 2014-01-28

Sunitinib in Treating Young Patients With Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
35 enrolled
CNSOther solid neoplasm

Central Nervous System Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡